BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29981794)

  • 1. Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses.
    Lundberg L; Brahms A; Hooper I; Carey B; Lin SC; Dahal B; Narayanan A; Kehn-Hall K
    Antiviral Res; 2018 Sep; 157():57-67. PubMed ID: 29981794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a cell-based ELISA as a screening tool identifying anti-alphavirus small-molecule inhibitors.
    Spurgers KB; Hurt CR; Cohen JW; Eccelston LT; Lind CM; Lingappa VR; Glass PJ
    J Virol Methods; 2013 Oct; 193(1):226-31. PubMed ID: 23764417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.
    Kendra JA; de la Fuente C; Brahms A; Woodson C; Bell TM; Chen B; Khan YA; Jacobs JL; Kehn-Hall K; Dinman JD
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27852852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.
    Rico AB; Phillips AT; Schountz T; Jarvis DL; Tjalkens RB; Powers AM; Olson KE
    Virology; 2016 Dec; 499():30-39. PubMed ID: 27632563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homoseongomycin, a compound isolated from marine actinomycete bacteria K3-1, is a potent inhibitor of encephalitic alphaviruses.
    Lin SC; Lehman CW; Stewart AK; Panny L; Bracci N; Wright JLC; Paige M; Strangman WK; Kehn-Hall K
    Antiviral Res; 2021 Jul; 191():105087. PubMed ID: 33965437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2.
    Chung DH; Jonsson CB; Tower NA; Chu YK; Sahin E; Golden JE; Noah JW; Schroeder CE; Sotsky JB; Sosa MI; Cramer DE; McKellip SN; Rasmussen L; White EL; Schmaljohn CS; Julander JG; Smith JM; Filone CM; Connor JH; Sakurai Y; Davey RA
    PLoS Pathog; 2014 Jun; 10(6):e1004213. PubMed ID: 24967809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of Venezuelan Equine Encephalitis Virus Identified Based on Host Interaction Partners of Viral Non-Structural Protein 3.
    Bakovic A; Bhalla N; Alem F; Campbell C; Zhou W; Narayanan A
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of FDA-Approved Anti-Inflammatory Drugs Against Venezuelan Equine Encephalitis Virus Infection.
    Risner K; Ahmed A; Bakovic A; Kortchak S; Bhalla N; Narayanan A
    Viruses; 2019 Dec; 11(12):. PubMed ID: 31842327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
    Erasmus JH; Seymour RL; Kaelber JT; Kim DY; Leal G; Sherman MB; Frolov I; Chiu W; Weaver SC; Nasar F
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29187545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule inhibitors of Ago2 decrease Venezuelan equine encephalitis virus replication.
    Madsen C; Hooper I; Lundberg L; Shafagati N; Johnson A; Senina S; de la Fuente C; Hoover LI; Fredricksen BL; Dinman J; Jacobs JL; Kehn-Hall K
    Antiviral Res; 2014 Dec; 112():26-37. PubMed ID: 25448087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff.
    Garmashova N; Gorchakov R; Volkova E; Paessler S; Frolova E; Frolov I
    J Virol; 2007 Mar; 81(5):2472-84. PubMed ID: 17108023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venezuelan equine encephalitis virus E1 protein interacts with PDIA6 and PDI inhibition reduces alphavirus production.
    Panny L; Akrhymuk I; Bracci N; Woodson C; Flor R; Elliott I; Zhou W; Narayanan A; Campbell C; Kehn-Hall K
    Antiviral Res; 2023 Apr; 212():105560. PubMed ID: 36822370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New World alphavirus protein interactomes from a therapeutic perspective.
    Carey BD; Bakovic A; Callahan V; Narayanan A; Kehn-Hall K
    Antiviral Res; 2019 Mar; 163():125-139. PubMed ID: 30695702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypervariable Domain of Eastern Equine Encephalitis Virus nsP3 Redundantly Utilizes Multiple Cellular Proteins for Replication Complex Assembly.
    Frolov I; Kim DY; Akhrymuk M; Mobley JA; Frolova EI
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable, high-level expression of reporter proteins from improved alphavirus expression vectors to track replication and dissemination during encephalitic and arthritogenic disease.
    Sun C; Gardner CL; Watson AM; Ryman KD; Klimstra WB
    J Virol; 2014 Feb; 88(4):2035-46. PubMed ID: 24307590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alphavirus antiviral drug development: scientific gap analysis and prospective research areas.
    Reichert E; Clase A; Bacetty A; Larsen J
    Biosecur Bioterror; 2009 Dec; 7(4):413-27. PubMed ID: 20028250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses.
    Reed DS; Glass PJ; Bakken RR; Barth JF; Lind CM; da Silva L; Hart MK; Rayner J; Alterson K; Custer M; Dudek J; Owens G; Kamrud KI; Parker MD; Smith J
    J Virol; 2014 Oct; 88(20):12077-86. PubMed ID: 25122801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzamidine ML336 inhibits plus and minus strand RNA synthesis of Venezuelan equine encephalitis virus without affecting host RNA production.
    Skidmore AM; Adcock RS; Jonsson CB; Golden JE; Chung DH
    Antiviral Res; 2020 Feb; 174():104674. PubMed ID: 31816348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approved drugs screening against the nsP1 capping enzyme of Venezuelan equine encephalitis virus using an immuno-based assay.
    Ferreira-Ramos AS; Li C; Eydoux C; Contreras JM; Morice C; Quérat G; Gigante A; Pérez Pérez MJ; Jung ML; Canard B; Guillemot JC; Decroly E; Coutard B
    Antiviral Res; 2019 Mar; 163():59-69. PubMed ID: 30639438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine Advances against Venezuelan, Eastern, and Western Equine Encephalitis Viruses.
    Stromberg ZR; Fischer W; Bradfute SB; Kubicek-Sutherland JZ; Hraber P
    Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32503232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.